Skip to main content
Top
Published in: Endocrine 3/2014

01-12-2014 | Editorial

Strict rules are needed for validation of G-protein-coupled receptor immunohistochemical studies in human tissues

Author: Jean Claude Reubi

Published in: Endocrine | Issue 3/2014

Login to get access

Excerpt

G-protein-coupled receptors (GPCR) constitute one of the largest families of cell surface proteins. Not only do they regulate, after activation by hormones and neurotransmitters, a considerable part of the physiological processes in the body, but they also represent a major class of drug targets and thus play an increasingly important role in medicine. Indeed, more than 30 % of the clinically marketed drugs do act through GPCR and are therapeutically successful in a large spectrum of human diseases. It is, therefore, evident that increasing information is needed on the expression and precise distribution of the GPCR, particularly in normal and diseased human tissues. The density of GPCR is usually considerably lower than that of other cellular parameters, such as that for hormones for instance, sometimes challenging their detection with current methods. …
Literature
2.
go back to reference C. Pyke, L.B. Knudsen, The glucagon-like peptide-1 receptor or not? Endocrinology 154, 4–8 (2013)PubMedCrossRef C. Pyke, L.B. Knudsen, The glucagon-like peptide-1 receptor or not? Endocrinology 154, 4–8 (2013)PubMedCrossRef
4.
go back to reference M.C. Michel, T. Wieland, G. Tsujimoto, How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs Arch. Pharmacol. 379, 385–388 (2009)PubMedCrossRef M.C. Michel, T. Wieland, G. Tsujimoto, How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs Arch. Pharmacol. 379, 385–388 (2009)PubMedCrossRef
5.
go back to reference A.C. Gore, Editorial: antibody validation requirements for articles published in endocrinology. Endocrinology 154, 579–580 (2013)PubMedCrossRef A.C. Gore, Editorial: antibody validation requirements for articles published in endocrinology. Endocrinology 154, 579–580 (2013)PubMedCrossRef
6.
go back to reference P.L. Fitzgibbons, L.A. Bradley, L.A. Fatheree, R. Alsabeh, R.S. Fulton, J.D. Goldsmith, T.S. Haas, R.G. Karabakhtsian, P.A. Loykasek, M.J. Marolt, S.S. Shen, A.T. Smith, P.E. Swanson, Principles of Analytic Validation of Immunohistochemical Assays: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center. Arch. Pathol. Lab. Med. (2014). doi:10.5858/arpa.2013-0610-CP PubMedCentral P.L. Fitzgibbons, L.A. Bradley, L.A. Fatheree, R. Alsabeh, R.S. Fulton, J.D. Goldsmith, T.S. Haas, R.G. Karabakhtsian, P.A. Loykasek, M.J. Marolt, S.S. Shen, A.T. Smith, P.E. Swanson, Principles of Analytic Validation of Immunohistochemical Assays: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center. Arch. Pathol. Lab. Med. (2014). doi:10.​5858/​arpa.​2013-0610-CP PubMedCentral
7.
go back to reference D.S. Dichmann, C. Rescan, U. Frandsen, P. Serup, Unspecific labeling of pancreatic islets by antisera against fibroblast growth factors and their receptors. J. Histochem. Cytochem. 51, 397–400 (2003)PubMedCrossRef D.S. Dichmann, C. Rescan, U. Frandsen, P. Serup, Unspecific labeling of pancreatic islets by antisera against fibroblast growth factors and their receptors. J. Histochem. Cytochem. 51, 397–400 (2003)PubMedCrossRef
8.
go back to reference C.R. Shyr, C.C. Chen, T.F. Hsieh, C.H. Chang, W.L. Ma, S. Yeh, E. Messing, T.H. Li, F.Y. Li, C. Chang, The expression and actions of androgen receptor in upper urinary tract urothelial carcinoma (UUTUC) tissues and the primary cultured cells. Endocrine 43, 191–199 (2013)PubMedCrossRef C.R. Shyr, C.C. Chen, T.F. Hsieh, C.H. Chang, W.L. Ma, S. Yeh, E. Messing, T.H. Li, F.Y. Li, C. Chang, The expression and actions of androgen receptor in upper urinary tract urothelial carcinoma (UUTUC) tissues and the primary cultured cells. Endocrine 43, 191–199 (2013)PubMedCrossRef
9.
go back to reference J.C. Reubi, B. Waser, R. Cescato, B. Gloor, C. Stettler, E. Christ, Internalized Sst2 receptors in neuroendocrine tumors of octreotide-treated patients. J. Clin. Endocrinol. Metab. 95, 2343–2350 (2010)PubMedCentralPubMedCrossRef J.C. Reubi, B. Waser, R. Cescato, B. Gloor, C. Stettler, E. Christ, Internalized Sst2 receptors in neuroendocrine tumors of octreotide-treated patients. J. Clin. Endocrinol. Metab. 95, 2343–2350 (2010)PubMedCentralPubMedCrossRef
10.
go back to reference B. Waser, M.L. Tamma, R. Cescato, H.R. Maecke, J.C. Reubi, Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissues. J. Nucl. Med. 50, 936–941 (2009)PubMedCrossRef B. Waser, M.L. Tamma, R. Cescato, H.R. Maecke, J.C. Reubi, Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissues. J. Nucl. Med. 50, 936–941 (2009)PubMedCrossRef
11.
go back to reference M. Korner, B. Waser, A. Schonbrunn, A. Perren, J.C. Reubi, Somatostatin receptors subtype 2A immunohistochemistry using a new monoclonal antibody selects tumors suitable for in vivo somatostatin receptor targeting. Am. J. Surg. Pathol. 36, 242–252 (2012)PubMedCentralPubMedCrossRef M. Korner, B. Waser, A. Schonbrunn, A. Perren, J.C. Reubi, Somatostatin receptors subtype 2A immunohistochemistry using a new monoclonal antibody selects tumors suitable for in vivo somatostatin receptor targeting. Am. J. Surg. Pathol. 36, 242–252 (2012)PubMedCentralPubMedCrossRef
12.
go back to reference L. Chinezu, A. Vasiljevic, E. Jouanneau, P. Francois, A. Borda, J. Trouillas, G. Raverot, Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies. Hum. Pathol. 45, 71–77 (2014)PubMedCrossRef L. Chinezu, A. Vasiljevic, E. Jouanneau, P. Francois, A. Borda, J. Trouillas, G. Raverot, Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies. Hum. Pathol. 45, 71–77 (2014)PubMedCrossRef
13.
go back to reference B. Gier, P.C. Butler, C.K. Lai, D. Kirakossian, M.M. DeNicola, M.W. Yeh, Glucagon like peptide-1 receptor expression in the human thyroid gland. J. Clin. Endocrinol. Metab. 97, 121–131 (2012)PubMedCentralPubMedCrossRef B. Gier, P.C. Butler, C.K. Lai, D. Kirakossian, M.M. DeNicola, M.W. Yeh, Glucagon like peptide-1 receptor expression in the human thyroid gland. J. Clin. Endocrinol. Metab. 97, 121–131 (2012)PubMedCentralPubMedCrossRef
Metadata
Title
Strict rules are needed for validation of G-protein-coupled receptor immunohistochemical studies in human tissues
Author
Jean Claude Reubi
Publication date
01-12-2014
Publisher
Springer US
Published in
Endocrine / Issue 3/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0320-0

Other articles of this Issue 3/2014

Endocrine 3/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.